PubMed

Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN.

Ann Intern Med. 2002 Jul 2;137(1):59-69. Review.PMID: 12093250 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

Levine M, Moutquin JM, Walton R, Feightner J; Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

CMAJ. 2001 Jun 12;164(12):1681-90. Review.PMID: 11450210 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.

[No authors listed]

Ann Intern Med. 2002 Jul 2;137(1):I62. No abstract available. PMID: 12093267 [PubMed - indexed for MEDLINE]Related articlesFree article

Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.

[No authors listed]

Harv Womens Health Watch. 2002 Oct;10(2):1-2. No abstract available. PMID: 12393316 [PubMed - indexed for MEDLINE]Related articles

From adjuvant therapy to breast cancer prevention: BCPT and STAR.

Dunn BK, Ford LG.

Breast J. 2001 May-Jun;7(3):144-57. Review.PMID: 11469927 [PubMed - indexed for MEDLINE]Related articles

Chemoprevention of breast cancer: recommendations and rationale.

U.S. Preventive Services Task Force.

Ann Intern Med. 2002 Jul 2;137(1):56-8. No abstract available. PMID: 12093249 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemoprevention of breast cancer.

Thomsen A, Kolesar JM.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2221-8. Review.PMID: 19020189 [PubMed - indexed for MEDLINE]Related articles

The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Wolmark N.

Clin Breast Cancer. 2002 Jun;3(2):153-9.PMID: 12123540 [PubMed - indexed for MEDLINE]Related articles

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH.

J Natl Cancer Inst. 2003 Apr 2;95(7):526-32.PMID: 12671020 [PubMed - indexed for MEDLINE]Related articlesFree article

American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.

Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG.

J Clin Oncol. 1999 Jun;17(6):1939-55. Review.PMID: 10561236 [PubMed - indexed for MEDLINE]Related articles

The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

Martino S, Costantino J, McNabb M, Mershon J, Bryant K, Powles T, Secrest RJ.

Oncologist. 2004;9(2):116-25. Review.PMID: 15047916 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemoprevention of breast cancer: implications for postmenopausal women.

Fabian CJ, Kimler BF.

Drugs Aging. 2002;19(1):43-78. Review.PMID: 11929326 [PubMed - indexed for MEDLINE]Related articles

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL 3rd, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N; National Surgical Adjuvant Breast and Bowel Project (NSABP).

JAMA. 2006 Jun 21;295(23):2727-41. Epub 2006 Jun 5. Erratum in: JAMA. 2006 Dec 27;296(24):2926. JAMA. 2007 Sep 5;298(9):973. PMID: 16754727 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemoprevention for high-risk women: tamoxifen and beyond.

Fabian CJ, Kimler BF.

Breast J. 2001 Sep-Oct;7(5):311-20. Review.PMID: 11906441 [PubMed - indexed for MEDLINE]Related articles

Chemoprevention of breast cancer.

Dalton RR, Kallab AM.

South Med J. 2001 Jan;94(1):7-15. Review.PMID: 11213947 [PubMed - indexed for MEDLINE]Related articles

Chemoprevention of breast cancer in the older patient.

Minton SE.

Hematol Oncol Clin North Am. 2000 Feb;14(1):113-30. Review.PMID: 10680075 [PubMed - indexed for MEDLINE]Related articles

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.

Chlebowski RT, Col N, Winer EP, Collyar DE, Cummings SR, Vogel VG 3rd, Burstein HJ, Eisen A, Lipkus I, Pfister DG; American Society of Clinical Oncology Breast Cancer Technology Assessment Working Group.

J Clin Oncol. 2002 Aug 1;20(15):3328-43. Review.PMID: 12149307 [PubMed - indexed for MEDLINE]Related articles

Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.

Ganz PA, Land SR.

Menopause. 2008 Jul-Aug;15(4 Suppl):797-803. Review.PMID: 18596601 [PubMed - indexed for MEDLINE]Related articles

Raloxifene: a review of its use in the prevention of invasive breast cancer.

Moen MD, Keating GM.

Drugs. 2008;68(14):2059-83. Review.PMID: 18778124 [PubMed - indexed for MEDLINE]Related articles

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

J Clin Oncol. 2009 Jul 1;27(19):3235-58. Epub 2009 May 26.PMID: 19470930 [PubMed - indexed for MEDLINE]Related articles